Parexel Best CRO 2023 – Parexel Voted Best CRO Globally
Parexel, a renowned and prominent global clinical research organization (CRO), has achieved a remarkable milestone. It has been awarded the prestigious title of “Top CRO to Work With” in the 2023 WCG CenterWatch Global Site Relationship Benchmark Survey. Parexel earned this recognition by outshining 33 other CROs, attaining the highest average rating across all 26 evaluated performance attributes.
The survey aimed to assess the quality of relationships between CROs and investigative sites worldwide. Respondents, including sites and individuals with direct experience or knowledge of the CROs, rated their performance on various attributes. In addition to being rated the highest overall, Parexel excelled in four out of the five most crucial attributes and emerged as the most recommended CRO by investigative sites.
Apply for Parexel Job Here: Biological Sciences Parexel Sr. Clinical Research Associate Recruitment
Teri Karcher, PhD, Executive Vice President, expressed the significance of Parexel’s leading position, acknowledging the increas
ing complexity of study start-ups and the immense pressure on investigative sites. By fostering strong relationships with these sites, Parexel aims to ensure successful clinical trial outcomes while meeting deadlines and budgets.This year’s achievement builds upon Parexel’s previous recognition as the “Top CRO to Work With” in the 2021 survey. Clare Grace, PhD, Chief Patient Officer, emphasized the importance of investigative site relationships in a patient-led clinical research model. The consecutive recognition reinforces Parexel’s commitment to making a positive impact in the lives of patients by partnering with investigative sites throughout the drug development process.
The recently conducted 2023 WCG CenterWatch Global Site Relationship Benchmark Survey, which takes place biennially, drew participation from a staggering number of over 60,000 individuals representing investigative sites across the globe. The survey ensured the anonymity of respondents while covering a wide range of regions including North America, Central and South America, Europe, Africa, and the Asia-Pacific.
Parexel, with its team of more than 21,000 professionals, offers a comprehensive range of Phase I to IV clinical development services. Their goal is to accelerate the delivery of life-saving treatments by working closely with biopharmaceutical leaders and emerging innovators. With a focus on patient-centered clinical trials, Parexel aims to increase access and participation in research, making it an option for anyone, anywhere.
In the ever-evolving landscape of clinical research, Parexel’s expertise, industry knowledge, and operational excellence continue to drive advancements. Their unwavering commitment is to enhance each stage of the clinical trial process, with patients always at the heart of their endeavours.
For more information about Parexel and their impactful work, visit parexel.com or connect with them on LinkedIn, Twitter, Facebook, and Instagram. Stay tuned for further updates from the leading CRO that’s making a real difference in healthcare.
